Departments of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Brain Pathol. 2022 Jul;32(4):e13062. doi: 10.1111/bpa.13062. Epub 2022 Mar 14.
Over the last decade, developments in molecular profiling have radically altered the diagnosis, classification, and management of numerous cancer types, with primary brain tumors being no exception. Although historically brain tumors have been classified based on their morphological characteristics, recent advances have allowed refinement of tumor classification based on molecular alterations. This shift toward molecular classification of primary brain tumors is reflected in the 2021 5 edition of the WHO classification of central nervous system tumors (WHO 2021). In this review, we will discuss the most recent updates to the classification of adult-type diffuse gliomas, a group of highly infiltrative and largely incurable CNS malignancies. It is our hope continued that refinement of molecular criteria will improve diagnosis, prognostication, and eventually treatment of these devastating tumors.
在过去的十年中,分子谱分析的发展彻底改变了许多癌症类型的诊断、分类和治疗,原发性脑肿瘤也不例外。尽管脑肿瘤的历史分类基于其形态学特征,但最近的进展允许根据分子改变对肿瘤分类进行细化。这种向原发性脑肿瘤的分子分类的转变反映在 2021 年版的世界卫生组织中枢神经系统肿瘤分类(WHO 2021)中。在这篇综述中,我们将讨论成人弥漫性胶质瘤分类的最新更新,这是一组高度浸润性且基本无法治愈的中枢神经系统恶性肿瘤。我们希望分子标准的细化将改善这些毁灭性肿瘤的诊断、预后,并最终改善治疗。